The Food and Drug Administration (FDA) has approved Journavx™ (suzetrigine) for the treatment of moderate to severe acute pain in adults.

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

Antidepressants may also be helpful in managing urinary incontinence (unintentionally passing urine) and stress incontinence (passing urine when there’s pressure on the bladder from coughing, jumping, ...

Vertex has gained the FDA's approval for its nonaddictive pain med Journavx, which becomes the first significant innovation ...

The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC ...

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often ...

Have you experienced pain or tingling in your hands or feet? Those are signs of possible neuropathy, “a general term for ...

This post hoc analysis did not find a differential effect of age on duloxetine treatment in non-depressed patients with OA knee pain. This is an important finding as it suggests that duloxetine is ...

This can lead to stomach problems and pain. Diabetes is a chronic condition in which the body either doesn’t make enough insulin (a hormone that allows cells to take in glucose from the blood) or ...

Advancements in non-opioid therapies, AI-integrated solutions, and regenerative medicine drive transformative growth in the pain management market. AUSTIN, TX, UNITED STATES, January 21, 2025 ...

Duloxetine, milnacipran and pregabalin can relieve pain for a small proportion of adults with fibromyalgia. Other treatments had no data or low-quality evidence with potential bias. Duloxetine ...